MESOTHELIOMA | 2026-11-15

Why Market-Share Liability Generally Does Not Apply to Asbestos Cases in California: Sindell, Mullen, and the Exposure Requirement

How California created market-share liability for DES in Sindell, why the courts refused to extend it to asbestos in Mullen, and what asbestos plaintiffs must prove instead under Rutherford

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

In most product liability cases, a plaintiff must prove that a particular defendant's product caused the injury. But California once recognized a striking exception: in cases involving the drug DES, where it was impossible to identify which manufacturer made the pills a plaintiff mother took decades...

The General Rule: Prove Which Product Caused the Harm

The ordinary rule of product liability is that a plaintiff must identify the specific product, made by the specific defendant, that caused the injury. This "product identification" requirement follows from the basic principle that a defendant is liable for the harm its own product caused, not for harm caused by products made by others. In most cases the requirement is unremarkable: the plaintiff knows which car, which machine, or which device was involved. But in a narrow class of cases — where a fungible product made by many manufacturers causes a disease that appears long after exposure, and the plaintiff cannot identify whose product they encountered — the product-identification requirement can become an insurmountable barrier. California confronted that problem in the DES litigation.

Sindell v. Abbott Laboratories: Market-Share Liability for DES

In Sindell v. Abbott Laboratories, 26 Cal.3d 588 (1980), the California Supreme Court created the doctrine of market-share liability. The plaintiffs were women injured by DES, a drug their mothers had taken during pregnancy, but because DES was a fungible product made by many manufacturers to an identical formula and ingested decades earlier, the plaintiffs could not identify which manufacturer made the pills their mothers took. The Court held that, under those specific conditions, a plaintiff who joined manufacturers representing a substantial share of the relevant market could shift the burden to each defendant to prove it did not make the product that caused the harm, with liability apportioned according to each manufacturer's share of the market. Sindell was a deliberate, narrow response to an extraordinary problem: a fungible product, identical across manufacturers, causing a signature injury with no way to identify the specific maker.

Mullen v. Armstrong World Industries: Asbestos Is Different

Asbestos plaintiffs asked the courts to extend Sindell to asbestos, and California courts declined. In Mullen v. Armstrong World Industries, Inc., 200 Cal.App.3d 250 (1988), the Court of Appeal refused to apply market-share liability to asbestos products. The court reasoned that asbestos is fundamentally unlike DES. DES was a single, chemically identical product; asbestos-containing products, by contrast, are not fungible — they varied enormously in the type and amount of asbestos they contained, in their fiber type, in their friability, and in the exposure they created. A worker exposed to one manufacturer high-asbestos insulation faced a different risk than a worker exposed to another manufacturer product containing little asbestos tightly bound in a matrix. Because asbestos products are not interchangeable in the way DES pills were, the premise of market-share liability — that each unit of the product carried an identical risk, so that market share fairly approximated the probability that a given manufacturer caused the harm — does not hold for asbestos. Applying market share to asbestos would impose liability on manufacturers in proportion to their market presence rather than in proportion to the risk their particular products actually created. The rule is not absolute: in Wheeler v. Raybestos-Manhattan, 8 Cal.App.4th 1152 (1992), the Court of Appeal held that market-share liability could be applied to asbestos brake pads, which contained roughly comparable amounts of a single fiber type, chrysotile, and so were treated as fungible. Outside that kind of showing, the Mullen rule controls.

What Asbestos Plaintiffs Must Prove Instead

Because market-share liability is unavailable, an asbestos plaintiff in California must prove exposure to each defendant asbestos-containing product and that the exposure was a substantial factor in causing the disease. The governing framework comes from Rutherford v. Owens-Illinois, Inc., 16 Cal.4th 953 (1997), in which the California Supreme Court held that an asbestos plaintiff must show that exposure to a particular defendant's product was a substantial factor contributing to the aggregate dose of asbestos the plaintiff inhaled, and hence to the risk of developing asbestos-related cancer. The plaintiff need not prove that fibers from a specific defendant product were the ones that actually caused the malignant cell, which would be impossible; but the plaintiff must prove exposure to that defendant's product and that the exposure contributed to the risk. The threshold exposure requirement was addressed in Lineaweaver v. Plant Insulation Co., 31 Cal.App.4th 1409 (1995), which required proof, in reasonable medical probability based on competent expert testimony, that the defendant's conduct contributed to the injury, and identified the frequency and regularity of exposure and the proximity of the asbestos product to the plaintiff as relevant factors. This is a demanding, product-specific proof requirement — the opposite of the market-share approach, which, where it applies, relieves the plaintiff of identifying the particular manufacturer of the product that caused the harm.

Why the Distinction Matters

The general refusal to apply market-share liability to asbestos shapes nearly every asbestos case in California. It means that an asbestos plaintiff ordinarily cannot simply sue the manufacturers with the largest market shares and let liability be apportioned by market presence. Instead, the plaintiff must do the harder work of identifying the specific products the plaintiff was exposed to — on the job sites where the plaintiff worked, in the equipment the plaintiff serviced, in the buildings where the plaintiff was present — and proving that each exposure was a substantial factor in causing the disease. This product-identification and exposure proof is the central battleground of asbestos litigation, and it is why asbestos cases depend so heavily on reconstructing a worker's history: the job sites, the trades, the specific products present, and the ways the plaintiff encountered them. The Mullen decision, by closing the market-share shortcut for non-fungible asbestos products, placed that proof at the heart of most cases.

How Plaintiffs Meet the Exposure Burden

Although the exposure requirement is demanding, asbestos plaintiffs can meet it through careful investigation. Product identification can come from the plaintiff's own testimony about the products they worked with, from co-workers who recall the brands used at a job site, from employment and purchasing records, from the documented practices of particular industries and trades, and from the extensive historical record of which manufacturers products were present in which settings. Expert testimony connects the identified exposures to the plaintiff's disease under the Rutherford substantial-factor standard. The proof is circumstantial and historical, often reconstructed decades after the exposure, but it can be developed — and California courts have made clear that circumstantial evidence of exposure can be sufficient to reach a jury. The point is not that asbestos plaintiffs cannot recover without market-share liability; it is that they must build their cases on product-specific exposure proof rather than on a market-apportionment shortcut.

Market-Share Liability in the Broader Toxic-Tort Landscape

The Sindell-Mullen contrast illustrates a broader principle in California toxic-tort law: market-share liability is a narrow, exceptional doctrine confined to products that are genuinely fungible and carry an identical risk. California courts have rarely extended it beyond the DES context, precisely because few products share DES defining features. Asbestos, with its wildly varying fiber content and risk, is generally treated as a product too heterogeneous for market share, with the narrow exception of products shown to be fungible, such as the brake pads in Wheeler. Other alternative-liability theories — such as the burden-shifting approach of Summers v. Tice, where two defendants acted negligently but only one caused the harm — are likewise confined to their own narrow circumstances and do not supply a general substitute for product identification in asbestos cases. The result is a legal landscape in which asbestos plaintiffs recover by proving exposure, not by apportioning liability across a market.

Practical Significance for California Victims

For a California mesothelioma or asbestos-disease victim, the practical lesson is that the strength of a case depends on the quality of the exposure investigation. Because the law requires proof of exposure to each defendant's product, the work of identifying the products, the job sites, and the manner of exposure — and of connecting them to the disease through expert testimony under Rutherford — is what determines the strength of a case. A victim who understands this can appreciate why experienced asbestos counsel devote so much effort to reconstructing a work and exposure history, interviewing co-workers, and gathering historical product information. Market-share liability would have made that work unnecessary, but California law, in Mullen, chose product-specific proof instead. This proof can often be assembled through a thorough investigation, although every case depends on its own facts. Victims can learn more by connecting with California asbestos attorneys.

The Four Conditions Behind Sindell

Understanding why asbestos does not fit market-share liability requires understanding the conditions that justified the doctrine in Sindell. The doctrine rested on a particular confluence of facts: the product was fungible, made to an identical formula by all manufacturers so that each unit carried the same risk; the plaintiff inability to identify the specific manufacturer was through no fault of her own, arising from the passage of time and the generic nature of the product; the plaintiff could join manufacturers of a substantial share of the relevant market, so that the apportionment would reasonably approximate responsibility; and each defendant joined had actually produced the product during the relevant period, so that every defendant was a potential source of the harm. Each of these conditions did work in Sindell, and the Court was careful to frame the doctrine as a response to that specific situation rather than a general relaxation of the causation requirement.

Asbestos fails the first and most important condition. Asbestos-containing products were not fungible: they ranged from products that were almost entirely asbestos to products in which a small amount of asbestos was tightly bound, from friable insulation that released clouds of fibers to solid products that released few, and from one fiber type to another with different biological potency. Because the risk created by one manufacturer product could be many times that created by another, apportioning liability by market share would systematically misallocate responsibility — charging a manufacturer of low-risk products in proportion to its market presence rather than the small risk its products actually created, and under-charging a manufacturer of high-risk products with a smaller market share. That mismatch between market share and actual risk is precisely why Mullen held the doctrine inapplicable to asbestos.

Other Theories Do Not Fill the Gap

Plaintiffs have occasionally invoked other theories that shift or relax the causation burden, but none supplies a general substitute for product identification in asbestos cases. Alternative liability, from Summers v. Tice, 33 Cal.2d 80 (1948), shifts the burden of proof on causation to multiple defendants when each acted negligently and only one caused the harm, but it applies to a small number of identified wrongdoers all before the court, not to an industry of many manufacturers whose products the plaintiff cannot identify. Concert of action and civil conspiracy can extend liability to those who agreed to or substantially assisted a wrong, but they require proof of the agreement or assistance and do not excuse the plaintiff from proving exposure to a defendant's product. Enterprise liability, which would impose liability on an entire industry that jointly controlled product design, has not been adopted as a general asbestos theory in California. The consistent thread is that these doctrines are narrow responses to particular problems, not a back door around the exposure requirement that Rutherford and Lineaweaver impose. For the asbestos plaintiff, the path to recovery runs through product-specific exposure proof, and the investigation that produces that proof is where cases are built.

California courts have generally held this line in the decades since Mullen, departing from it only where a plaintiff shows that a particular category of asbestos products was genuinely fungible, as in Wheeler; the reasoning rests on the factual reality that most asbestos products were genuinely different from one another in the risk they created. Rather than erode the causation requirement, California courts have refined the exposure standard itself — clarifying in later decisions how frequency, regularity, and proximity of exposure are shown, and how expert testimony connects a proven exposure to the aggregate dose under Rutherford. The effect is a body of law that demands real proof of exposure to each defendant's product while giving plaintiffs workable, well-established methods for supplying it.

Related Guides

For related reading, see our injury and asbestos news, and learn more about the firm's work representing victims as California mesothelioma lawyers and on asbestos trust claims.

Frequently Asked Questions

What is market-share liability?

It is a doctrine, created in Sindell v. Abbott Laboratories, 26 Cal.3d 588 (1980), that allows liability to be apportioned among manufacturers of a fungible product by their share of the market when the plaintiff cannot identify which manufacturer made the specific product that caused the harm. It was developed for DES.

Does market-share liability apply to asbestos in California?

Generally, no. In Mullen v. Armstrong World Industries, 200 Cal.App.3d 250 (1988), the Court of Appeal refused to apply market-share liability to asbestos, because asbestos products are not fungible — they vary greatly in fiber type, content, and the risk they create — so market share does not fairly approximate causation. A narrow exception exists where a plaintiff shows a category of products was fungible: in Wheeler v. Raybestos-Manhattan, 8 Cal.App.4th 1152 (1992), the court allowed market-share liability for asbestos brake pads.

Why is asbestos different from DES?

DES was a single, chemically identical drug, so each unit carried the same risk and market share approximated the probability a given manufacturer caused the harm. Asbestos products varied enormously in type and amount of asbestos and in the exposure they created, so they are not interchangeable and the premise of market share does not hold.

What must an asbestos plaintiff prove instead?

Exposure to each defendant asbestos-containing product, and that the exposure was a substantial factor contributing to the aggregate dose and the risk of disease, under Rutherford v. Owens-Illinois, 16 Cal.4th 953 (1997). The threshold exposure showing is addressed in Lineaweaver v. Plant Insulation, 31 Cal.App.4th 1409 (1995).

Does the plaintiff have to prove which fibers caused the cancer?

No. Rutherford recognizes that identifying the specific fibers that caused the malignant cell is impossible. The plaintiff must prove exposure to the defendant's product and that it contributed to the risk of developing the disease — a substantial-factor standard, not a but-for identification of the causative fiber.

How do plaintiffs prove exposure decades later?

Through the plaintiff's own testimony, co-worker recollections, employment and purchasing records, documented industry and trade practices, and the historical record of which products were present in which settings, connected to the disease by expert testimony. Circumstantial evidence of exposure can be sufficient to reach a jury.

Can I still recover without market-share liability?

Yes, recovery remains possible. Asbestos plaintiffs pursue their claims by proving product-specific exposure. The absence of market-share liability means the case is built on exposure investigation rather than market apportionment, and that proof can often be developed through a thorough investigation, although no particular outcome is guaranteed.

Why does this make the exposure investigation so important?

Because the law requires proof of exposure to each defendant's product, the quality of the investigation into the products, job sites, and manner of exposure directly determines the strength of the case. That is why experienced asbestos counsel invest heavily in reconstructing a worker's exposure history.

Speak With a California Mesothelioma Attorney

If you or a loved one has been diagnosed with mesothelioma or another asbestos-related disease, proving which companies products caused your exposure is the heart of the case, because California law generally does not allow market-share liability for asbestos. Trembach Law Firm reconstructs work and exposure histories, identifies the specific responsible products and defendants, and develops the substantial-factor proof that Rutherford requires. For a free consultation, call (213) 645-2246. Because asbestos cases turn on product-specific exposure proof rather than a market-apportionment shortcut, a thorough investigation by experienced counsel is essential to building the case.

This article is provided for general informational purposes only and is not legal advice. Reading it does not create an attorney-client relationship. Every case depends on its own facts, and no particular outcome is guaranteed.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301